Case studies outlining use of nebulized morphine for patients with end-stage chronic lung and cardiac disease.
This article describes the use of nebulized morphine in the management of dyspnea in two patients with end-stage chronic lung disease, and two patients with end-stage heart failure. All four patients had relief of breathlessness. Arterial blood gas results and vital signs were monitored pre- and postnebulized morphine in two of the patients and demonstrated little change. Nebulized morphine appears to be well tolerated in this patient population.
Palliative Care Service, Ottawa Civic Hospital, Ontario, Canada.
M
M
Farncombe
S
S
Chater
D000368:Aged; D002303:Cardiac Output, Low / Q000150:complications*; D002908:Chronic Disease; D004417:Dyspnea / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000150:complications*; D008297:Male; D009020:Morphine / Q000008:administration & dosage*; D009330:Nebulizers and Vaporizers
D009020:Morphine